BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33939630)

  • 1. No Serological Evidence of Trachoma or Yaws Among Residents of Registered Camps and Makeshift Settlements in Cox's Bazar, Bangladesh.
    Cooley GM; Feldstein LR; Bennett SD; Estivariz CF; Weil L; Bohara R; Vandenent M; Mainul Hasan A; Akhtar MS; Uzzaman MS; Billah MM; Conklin L; Ehlman DC; Asiedu K; Solomon AW; Alamgir A; Flora MS; Martin DL
    Am J Trop Med Hyg; 2021 May; 104(6):2031-2037. PubMed ID: 33939630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji.
    Cocks N; Rainima-Qaniuci M; Yalen C; Macleod C; Nakolinivalu A; Migchelsen S; Roberts CH; Butcher R; Kama M; Mabey D; Marks M
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):582-587. PubMed ID: 27852877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study.
    Feldstein LR; Bennett SD; Estivariz CF; Cooley GM; Weil L; Billah MM; Uzzaman MS; Bohara R; Vandenent M; Adhikari JM; Leidman E; Hasan M; Akhtar S; Hasman A; Conklin L; Ehlman D; Alamgir A; Flora MS
    PLoS Med; 2020 Mar; 17(3):e1003071. PubMed ID: 32231368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL; Bid R; Sandi F; Goodhew EB; Massae PA; Lasway A; Philippin H; Makupa W; Molina S; Holland MJ; Mabey DC; Drakeley C; Lammie PJ; Solomon AW
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
    Senyonjo LG; Debrah O; Martin DL; Asante-Poku A; Migchelsen SJ; Gwyn S; deSouza DK; Solomon AW; Agyemang D; Biritwum-Kwadwo N; Marfo B; Bakajika D; Mensah EO; Aboe A; Koroma J; Addy J; Bailey R
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007027. PubMed ID: 30550537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Serological Evidence of Exposure to
    Handley BL; Butcher R; Taoaba R; Roberts CH; Cama A; Müeller A; Solomon AW; Tekeraoi R; Marks M
    Am J Trop Med Hyg; 2019 Apr; 100(4):940-942. PubMed ID: 30719964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma.
    Marks M; Sokana O; Nachamkin E; Puiahi E; Kilua G; Pillay A; Bottomley C; Solomon AW; Mabey DC
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004927. PubMed ID: 27551787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of immunity to polio among Rohingya children in Cox's Bazar, Bangladesh, 2018: A cross-sectional survey.
    Estivariz CF; Bennett SD; Lickness JS; Feldstein LR; Weldon WC; Leidman E; Ehlman DC; Khan MFH; Adhikari JM; Hasan M; Billah MM; Oberste MS; Alamgir ASM; Flora MD
    PLoS Med; 2020 Mar; 17(3):e1003070. PubMed ID: 32231366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
    Gwyn S; Nute AW; Sata E; Tadesse Z; Chernet A; Haile M; Zeru T; Bethea D; Laurent C; Callahan EK; Nash SD; Martin DL
    Am J Trop Med Hyg; 2021 Aug; 105(5):1362-1367. PubMed ID: 34398819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
    Kaur H; Dize L; Munoz B; Gaydos C; West SK
    J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey.
    West SK; Munoz B; Weaver J; Mrango Z; Dize L; Gaydos C; Quinn TC; Martin DL
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004352. PubMed ID: 26771906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP; Bhatta RC; Chaudhary JS; Awasthi S; Mishra S; Sharma S; Cuddapah PA; Gwyn SE; Stoller NE; Martin DL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo.
    Gwyn S; Awoussi MS; Bakhtiari A; Bronzan RN; Crowley K; Harding-Esch EM; Kassankogno Y; Kilangalanga JN; Makangila F; Mupoyi S; Ngondi J; Ngoyi B; Palmer S; Randall JM; Seim A; Solomon AW; Stewart R; Togbey K; Uvon PA; Martin DL
    Sci Rep; 2021 Mar; 11(1):7225. PubMed ID: 33790370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia.
    Migchelsen SJ; Sepúlveda N; Martin DL; Cooley G; Gwyn S; Pickering H; Joof H; Makalo P; Bailey R; Burr SE; Mabey DCW; Solomon AW; Roberts CH
    Sci Rep; 2017 Nov; 7(1):15040. PubMed ID: 29118442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serosurvey of Treponema pallidum infection among children with skin ulcers in the Tarangire-Manyara ecosystem, northern Tanzania.
    Lubinza CKC; Lueert S; Hallmaier-Wacker LK; Ngadaya E; Chuma IS; Kazwala RR; Mfinanga SGM; Failing K; Roos C; Knauf S
    BMC Infect Dis; 2020 Jun; 20(1):392. PubMed ID: 32493291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a rapid test for antibodies to the Chlamydia trachomatis antigen Pgp3.
    Gwyn S; Mkocha H; Randall JM; Kasubi M; Martin DL
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):293-298. PubMed ID: 30709562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yaws in Polynesia's Wallis and Futuna Islands: a seroprevalence survey.
    Guerrier G; Marcon S; Garnotel L; Deltour R; Schinas S; Mathelin JP; Chouvin C; Metge O; Daronat JM
    N Z Med J; 2011 Apr; 124(1333):29-31. PubMed ID: 21750592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing seroprevalence and associated risk factors for multiple infectious diseases in Sabah, Malaysia using serological multiplex bead assays.
    Chan YL; Patterson CL; Priest JW; Stresman G; William T; Chua TH; Tetteh K; Lammie P; Drakeley C; Fornace KM
    Front Public Health; 2022; 10():924316. PubMed ID: 36388287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Mapping of Yaws and Trachoma in the Five Northern-Most Provinces of Vanuatu.
    Taleo F; Macleod CK; Marks M; Sokana O; Last A; Willis R; Garae M; Bong A; Chu BK; Courtright P; Kool J; Taleo G; Rory JJ; Solomon AW;
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005267. PubMed ID: 28118354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.